Posts belonging to Category Uncategorized
Posted by Site Administrator on April 10, 2013
Cytokinetics, Incorporated announced today the initiation of a first-time-in-humans, Phase I clinical trial of CK-2127107 in healthy male volunteers. Cytokinetics is developing CK-2127107, a novel small molecule activator of the fast skeletal muscle troponin complex, for the potential improvement of skeletal muscle function in diseases and medical conditions associated with neuromuscular dysfunction, muscular weakness, and/or muscle fatigue. Like tirasemtiv, the lead drug candidate from the company’s skeletal muscle activator program, CK-2127107 slows the rate of calcium release from the regulatory troponin complex of fast skeletal muscle fibers, which sensitizes the sarcomere to calcium.
Categories: ALS News, Clinical Trials, Research News, Treatments, Uncategorized
| 
Tags: ALS, ALS community, ALS funding, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Background on Fast Skeletal Muscle Activators ALS, BENEFIT-ALS (Blinded Evaluation of Neuromusclar Effects and Functional Improvement with Tirasemtiv in ALS), Bob Stehlin, CK-2127107, Cytokinetics Incorporated, Fady Malik, Lou Gehrig's disease, novel mechanism ALS, PALS, Phase I clinical trial, Phase I clinical trial CK-2127107, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Robert I. Blum, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, tirasemtiv ALS
| 
No comments
Posted by Site Administrator on March 20, 2013
MDA has awarded a $400,000 grant to National Institutes of Health (NIH) Laboratory of Neurogenetics researchers to perform exome sequencing on samples taken from 1,000 people with sporadic amyotrophic lateral sclerosis (ALS). The project will be led by neurologist Bryan Traynor, head of the Neuromuscular Diseases Research Group at the NIH in Bethesda, Md.
Categories: ALS News, Research News, Technology, Treatments, Uncategorized
| Tags: ALS, ALS community, ALS diagnosis, ALS diagnostics, ALS research, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, Coriell ALS Repository., DNA ALS, exome sequencing ALS, Lou Gehrig's disease, MDA translational research program, MDA Vice President of Research Jane Larkindale, Muscular Dystrophy Association MDA, National Institutes of Health (NIH), National Institutes of Health Laboratory of Neurogenetics, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, whole genome sequencing ALS
| No comments
Posted by Site Administrator on June 21, 2012
This morning, Eric Nolet, general director of the ALS Foundation of the Netherlands, opened the trading day by sounding the bell to highlight World ALS Day — or Wereld ALS Dag.
Categories: Uncategorized
| Tags: 501(c)(3) ALS charity, ALS, ALS community, ALS cure, ALS donations, ALS Foundation of the Netherlands, ALS funding, ALS medical care, ALS research, ALS research funding, amyotrophic lateral sclerosis, Bob Stehlin, Eric Nolet, Lou Gehrig’s disease, NYSE, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Wereld ALS Dag, World ALS Day
| No comments
Posted by Site Administrator on June 11, 2012
Saneron will use the cells for future clinical trials to study possible therapies for restoring brain tissue in patients suffering from Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), also known as “Lou Gehrig’s disease,” and the effects of stroke.
Categories: Uncategorized
| Tags: 501(c)(3) ALS charity, ALS, ALS community, ALS medical care, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, GenCure, Inc., Lou Gehrig's disease, Mary Beth Fisk, Nicole Kuzmin-Nichols, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Saneron CCEL Therapeutics, South Texas Blood & Tissue Center, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, U-CORD-CELL™
| No comments
Posted by Site Administrator on April 18, 2012
St. Louis- Upon hearing about his diagnosis of amyotrophic lateral sclerosis (ALS) in September 2009, Bob Stehlin vowed to fight the disease with all his strength. He started the RASCALS Foundation to bolster medical and social service programs for others with the fatal neurodegenerative disease who live in Eastern Missouri as well as in Central [...]
Categories: Uncategorized
| Tags: ALS across America, ALS Association, ALS Awareness, Home Service Oil, Laura Stehlin, Mary Riggs, May ALS Awareness, May ALS Awareness Month, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Robert Stehlin, St. Louis ALS Chapter, St. Louis University ALS Multidisciplinary Clinic
| No comments
Posted by Site Administrator on February 14, 2012
This Valentine’s Day, please make your tax-deductible contribution or micro-donation to the RASCALS Foundation.
Too much needs to be done.
No amount is too small.
Thank you!
Categories: 501(c)(3) Non-Profit, Uncategorized
| Tags: ALS, ALS community, ALS donation, ALS patient support, ALS research, ALS research funding, ALS scholarship funding, amyotrophic lateral sclerosis, Lou Gehrig's disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, SCHOLARSHIP, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, tax deductible
| No comments
Posted by Site Administrator on December 21, 2011
The U.S. Department of Veterans Affairs published regulations that would increase from 30% to 100% the minimum disability rating automatically provided to all veterans with ALS who qualify for service connected benefits.
Categories: Uncategorized
| Tags: 100% minimum disability rating, ALS, ALS community, amyotrophic lateral sclerosis, Lou Gehrig's disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, U.S. Department of Veterans Affairs, VA, Veterans, veterans with ALS
| No comments
Posted by Site Administrator on November 4, 2011
According to founder and president, Robert Stehlin, the award was created to “recognize those who have soared above and beyond the call of duty on behalf of the Foundation, and all patients with amyotrophic lateral sclerosis.”
Categories: Uncategorized
| Tags: ALS, ALS community, amyotrophic lateral sclerosis, Bobby Stehlin, Diana Stehlin, Lou Gehrig's disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Winged Warrior Award
| No comments
Posted by Site Administrator on August 2, 2011
L-R Anne Fann, Research Coordinator, Robert Stehlin, RASCALS Founder, Dr. Hayat, Clinical Director, Greg Reagan, RASCALS Treasurer
St. Louis, Missouri,
August 2, 2011
Story by,
Jennifer Hasamear
jhasamea@slu.edu
Robert Stehlin, a patient of SLUCare neurologist Dr. Ghazala Hayat, last week presented a check for $9,000 to help fund her research of Lou Gehrig’s disease, which is a degenerative neurological condition also [...]
Categories: Uncategorized
| No comments
Posted by Site Administrator on July 31, 2011
“The big guys like cancer and AIDS get the bulk of the research money,” he says adding that most of the other donation goes toward medical care and bettering quality of living for patients.
Categories: Uncategorized
| Tags: ALS, Lou Gehrig's disease, RASCALS Foundation, Robert A. Stehlin Campaign for ALS
| No comments
